J. Anim Sci.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kushibiki, S.
Right arrow Articles by Yokomizo, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kushibiki, S.
Right arrow Articles by Yokomizo, Y.

Journal of Animal Science, Vol 78, Issue 8 2164-2171, Copyright © 2000 by American Society of Animal Science

JOURNAL ARTICLE

Administration of recombinant bovine tumor necrosis factor-alpha affects intermediary metabolism and insulin and growth hormone secretion in dairy heifers

S. Kushibiki, K. Hodate, Y. Ueda, H. Shingu, Y. Mori, T. Itoh and Y. Yokomizo
Department of Animal Production, Tohoku National Agricultural Experimental Station, Iwate, Japan. mendoza@ss.tnaes.affrc.go.jp

Four experiments were conducted to clarify the effect of intravenous (i.v.) administration of recombinant bovine tumor necrosis factor alpha (rbTNF) on selected metabolites and on hormone secretion in Holstein heifers (n = 6; 347.0 kg average BW). In Exp. 1, rbTNF was injected at three dosage levels in a Latin square; 0 (CONT), 2.5 (TNF2.5), or 5.0 (TNF5) microg/kg BW. Plasma glucose and triglyceride concentrations were at first elevated (P < .05) by rbTNF treatment and then were decreased (P < .05) by TNF2.5 and TNF5. Plasma NEFA concentrations were increased (P < .05) in rbTNF-treated groups. The injection of rbTNF resulted in an increase in plasma insulin levels (P < .05 with TNF5) during the period between 2 and 24 h, except for the period between 6 and 8 h, after the treatment. In Exp. 2, 3, and 4, each heifer received i.v. injections of glucose (.625 mM/kg BW) + rbTNF (5 microg/kg) or glucose + saline (10 mL) (Exp. 2), insulin (0.2 U/kg) + rbTNF or insulin + saline (Exp. 3), and GHRH (0.25 microg/kg) + rbTNF or GHRH + saline (Exp. 4) at 1-wk intervals. In Exp. 2, rbTNF inhibited (P < .05) glucose-stimulated insulin secretion during the initial phase. Thereafter, plasma insulin was higher (P < .01) with the glucose + rbTNF treatment than with the glucose + saline treatment. Treatment with rbTNF inhibited the insulin-stimulated glucose utilization (Exp. 3) and GHRH-stimulated GH secretion (Exp. 4) during the initial phase. These results suggest that rbTNF directly and(or) indirectly affects the intermediary metabolism and hormone secretion in Holstein heifers.


This article has been cited by other articles:


Home page
 J ANIM SCIHome page
J. A. Daniel, T. H. Elsasser, C. D. Morrison, D. H. Keisler, B. K. Whitlock, B. Steele, D. Pugh, and J. L. Sartin
Leptin, tumor necrosis factor-{alpha} (TNF), and CD14 in ovine adipose tissue and changes in circulating TNF in lean and fat sheep
J Anim Sci, October 1, 2003; 81(10): 2590 - 2599.
[Abstract] [Full Text] [PDF]

Home page
 J DAIRY SCIHome page
S. Kushibiki, K. Hodate, H. Shingu, Y. Obara, E. Touno, M. Shinoda, and Y. Yokomizo
Metabolic and Lactational Responses during Recombinant Bovine Tumor Necrosis Factor-{alpha} Treatment in Lactating Cows
J Dairy Sci, March 1, 2003; 86(3): 819 - 827.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
S. Kushibiki, K. Hodate, H. Shingu, T. Hayashi, E. Touno, M. Shinoda, and Y. Yokomizo
Alterations in lipid metabolism induced by recombinant bovine tumor necrosis factor-alpha administration to dairy heifers
J Anim Sci, August 1, 2002; 80(8): 2151 - 2157.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society of Animal Science.